China Tower’s Stock Price Dips to 1.12 HKD, Records a Decline of 0.88%

China Tower (788)

1.12 HKD -0.01 (-0.88%) Volume: 270.84M

China Tower’s stock price stands at 1.12 HKD, experiencing a slight dip of -0.88% this trading session, despite a robust trading volume of 270.84M and a substantial YTD gain of +36.59%, showcasing its potential for investors interested in the Chinese market.

Latest developments on China Tower

China Tower (00788) has seen a series of block trades recently, with both bullish and bearish movements affecting the stock price. Bullish block trades of 2M shares at $1.12 and 2.4M shares at $1.12 have shown confidence in the company, with turnovers of $2.24M and $2.688M respectively. However, bearish block trades of 2M shares at $1.13, 3M shares at $1.13, and 1.8M shares at $1.1 have countered this positivity, with turnovers ranging from $2.26M to $3.39M. Despite this, a bullish block trade of 5M shares at $1.12 has provided a boost with a $5.6M turnover. Another bearish block trade of 1.9M shares at $1.11 has also impacted the stock with a $2.109M turnover.

China Tower on Smartkarma

Analyst coverage on China Tower on Smartkarma indicates potential changes in the iShares China Large-Cap (FXI) ETF. According to Brian Freitas, China Tower (788 HK) is likely to replace China International Capital Corporation (3908 HK) in the FXI at the close on 20 September. Passives are expected to buy 2x ADV in China Tower, with a noticeable increase in cumulative excess volume and short interest in CICC. The listing of Midea Group Co Ltd A (000333 CH) H-shares could also impact the ETF before the next scheduled rebalance in December.

In a preview of the FXI rebalance, Brian Freitas suggests that China Tower (788 HK) has a high probability of being included in the ETF while CICC (3908 HK) could be deleted. Shorts have been covering China Tower and increasing in CICC, with a slowdown in the pace of cumulative excess volume growth for both stocks in recent months. The analyst points out the potential for one change in the FXI ETF in September, with the possibility of another change if Wuxi Apptec underperforms other stocks by 3% over the next 4 weeks.

A look at China Tower Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Tower Corporation Limited, a telecommunications company, has received high scores in value and dividend, indicating strong financial performance and potential for returns to investors. However, the company scored lower in growth, resilience, and momentum, suggesting challenges in expanding its operations, adapting to market changes, and maintaining positive stock performance. Despite these mixed scores, China Tower’s widespread presence throughout China positions it well to capitalize on the country’s growing telecommunications industry.

Looking ahead, China Tower’s long-term outlook may be influenced by its ability to improve growth, resilience, and momentum scores. While the company’s strong value and dividend scores provide a solid foundation, addressing weaknesses in these areas could help enhance overall performance and investor confidence. As China continues to advance its telecommunications infrastructure, China Tower’s strategic positioning and service offerings may play a key role in shaping its future success in the industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma